Literature DB >> 11801757

Very late relapse of Hodgkin's disease: a report of five patients.

S Shihabi1, M Deutsch, S A Jacobs.   

Abstract

The majority of patients with Hodgkin's disease can be cured with current treatment modalities. Relapses beyond 3 years are rare; however, the outcome for patients in late relapse with standard-dose salvage therapy is excellent. In this article, we report five patients who had such relapses and describe their outcome.

Entities:  

Mesh：

Year:  2001        PMID： 11801757     DOI： 10.1097/00000421-200112000-00009

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN： 0277-3732            Impact factor:   2.339


  5 in total

1.  Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma.

Authors:  László Pinczés; Zsófia Miltényi; Árpád Illés
Journal:  J Cancer Res Clin Oncol       Date:  2018-02-21       Impact factor: 4.553

2.  Successful treatment with brentuximab vedotine for a patient with very late relapse of limited stage classic Hodgkin lymphoma.

Authors:  Jun Nukui; Hiroyuki Takahashi; Mayumi Tokunaga; Taisei Suzuki; Masaki Suzuki; Tomoyuki Yokose; Naoya Nakamura; Rika Sakai; Hideaki Nakajima
Journal:  Int Cancer Conf J       Date:  2021-09-15

3.  Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.

Authors:  Francesco Gaudio; Annamaria Giordano; Vincenzo Pavone; Tommasina Perrone; Paola Curci; Domenico Pastore; Mario Delia; Clara De' Risi; Alessandro Spina; Vincenzo Liso; Giorgina Specchia
Journal:  Adv Hematol       Date:  2010-12-29

4.  Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors.

Authors:  Theodoros P Vassilakopoulos; Evrydiki Kravvariti; Fotios Panitsas; Maria K Angelopoulou; Athanasios Liaskas; Flora N Kontopidou; Xanthoula Yiakoumis; Eleni Variami; Maria N Dimopoulou; Marina P Siakantaris; John V Asimakopoulos; Maria Arapaki; Maria Dimou; Panagiotis Diamantopoulos; Sotirios Sachanas; Chrysovalantou Chatzidimitriou; Marina Belia; Elianna Konstantinou; George Boutsikas; Kyriaki Petevi; Alexandros Kanellopoulos; Styliani Kokoris; Marie-Christine Kyrtsonis; Nora-Athina Viniou; Eleftheria Lakiotaki; Gerasimos Tsourouflis; Penelope Korkolopoulou; Kostas Konstantopoulos; Panayiotis Panayiotidis; Gerassimos A Pangalis
Journal:  Blood Cancer J       Date:  2022-07-05       Impact factor: 9.812

5.  Late recurrence in pediatric cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Karen Wasilewski-Masker; Qi Liu; Yutaka Yasui; Wendy Leisenring; Lillian R Meacham; Sue Hammond; Anna T Meadows; Leslie L Robison; Ann C Mertens
Journal:  J Natl Cancer Inst       Date:  2009-12-16       Impact factor: 11.816
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.